文献速递湿疹皮炎与荨麻疹性传播疾病

肛门生殖器皮炎患者斑贴试验结果分析

Evaluation of Patch Test Findings in Patients With Anogenital Dermatitis.
PubMed 文献 · JAMA Dermatol · 2020-01-01

仅肛门生殖器受累者中男性更常诊断为变应性接触性皮炎,女性更常为其他皮肤病;常见过敏原包括局部麻醉药和防腐剂。

要点

  • 仅肛门生殖器受累者中50.6%有至少1个相关斑贴试验阳性反应。
  • 男性比女性更易诊断为变应性接触性皮炎(60.5% vs 47.8%)。
  • 应测试防腐剂、香料、药物(尤其局部麻醉药)和局部糖皮质激素。

核心结论

  • 仅肛门生殖器受累的转诊患者中,男性更可能为变应性接触性皮炎,女性更可能为其他皮肤病。
  • 常见过敏原为可能接触肛门生殖器区域的物质,建议对疑似变应性接触性皮炎者测试防腐剂、香料、药物和局部糖皮质激素。

主要发现

  • 832例有肛门生殖器受累(336男,496女;平均[SD]年龄50.1[26.5]岁),449例仅肛门生殖器受累(177男,272女;平均[SD]年龄49.6[17.4]岁)。
  • 肛门生殖器受累组中,女性最终诊断为变应性接触性皮炎的比例显著低于男性(130/272 [47.8%] vs 107/177 [60.5%];相对危险度0.78;95%CI 0.64-0.94;P = .01),而其他皮肤病诊断更常见(67/272 [24.6%] vs 28/177 [15.8%];相对危险度1.54;95%CI 1.02-2.31;P = .03)。
  • 仅肛门生殖器受累的449例中,227例(50.6%)有1个或以上相关斑贴试验阳性反应。

关键数值与推荐

  • 肛门生殖器变应性接触性皮炎定义为仅肛门生殖器受累、变应性接触性皮炎为唯一诊断、且1个或以上当前临床相关阳性反应,共152例符合。

临床怎么用

  • 对肛门生殖器皮炎疑似变应性接触性皮炎者,斑贴试验应包含防腐剂、香料、药物(尤其局部麻醉药)和局部糖皮质激素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Contact dermatitis in the anogenital area is associated with sleep disturbance and dyspareunia and can profoundly affect quality of life. The literature on anogenital contact dermatitis and culprit allergens is limited. The last large-scale study on common, relevant allergens in patients with anogenital dermatitis was published in 2008. OBJECTIVES: To characterize patients with anogenital dermatitis referred for patch testing by the North American Contact Dermatitis Group, to identify common allergens, and to explore sex-associated differences between anogenital dermatitis and allergens. DESIGN, SETTING, AND PARTICIPANTS: A retrospective, cross-sectional analysis was conducted of the North American Contact Dermatitis Group database among 28 481 patients who underwent patch testing from January 1, 2005, to December 31, 2016, at outpatient referral clinics in the United States and Canada. EXPOSURE: Patch testing for allergens. MAIN OUTCOMES AND MEASURES: Currently relevant allergic patch test reactions in patients with anogenital dermatitis. RESULTS: Of 28 481 patients tested during the study period, 832 patients (336 men and 496 women; mean [SD] age, 50.1 [26.5] years) had anogenital involvement and 449 patients (177 men and 272 women; mean [SD] age, 49.6 [17.4] years) had anogenital dermatitis only. Compared with those without anogenital involvement, there were significantly more male patients in the group with anogenital dermatitis (177 [39.4%] vs 8857 of 27 649 [32.0%]; relative risk, 1.37; 95% CI, 1.14-1.66; P < .001). In the group with anogenital involvement, female patients were significantly less likely than male patients to have allergic contact dermatitis as a final diagnosis (130 [47.8%] vs 107 [60.5%]; relative risk, 0.78; 95% CI, 0.64-0.94; P = .01), whereas a final diagnosis of other dermatoses (eg, lichen planus, lichen sclerosus, or lichen simplex chronicus) was more frequent for female patients than for male patients (67 [24.6%] vs 28 [15.8%]; relative risk, 1.54; 95% CI, 1.02-2.31; P = .03). Of the 449 patients in the group with anogenital involvement only, 227 (50.6%) had 1 or more relevant reaction with patch testing. Allergens that were statistically significantly more common in patients with anogenital involvement compared with those without anogenital involvement included medicaments such as dibucaine (10 of 250 patients tested [4.0%] vs 32 of 17 494 patients tested [0.2%]; relative risk, 22.74; 95% CI, 11.05-46.78; P < .001) and preservatives such as methylchloroisothiazolinone and methylisothiazolinone (30 of 449 patients tested [6.7%] vs 1143 of 27 599 patients tested [4.1%]; relative risk, 1.61; 95% CI, 1.14-2.41; P = .008). A total of 152 patients met the definition for anogenital allergic contact dermatitis, which is defined as anogenital involvement only, allergic contact dermatitis as the only diagnosis, and 1 or more positive reaction of current clinical relevance. CONCLUSIONS AND RELEVANCE: For patients with anogenital involvement only who were referred for patch testing, male patients were more likely to have allergic contact dermatitis, whereas female patients were more likely to have other dermatoses. Common allergens or sources consisted of those likely to contact the anogenital area. For individuals with anogenital involvement suspected of having allergic contact dermatitis, reactions to preservatives, fragrances, medications (particularly topical anesthetics), and topical corticosteroids should be tested.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Warshaw EM, Kimyon RS, Silverberg JI, et al. Evaluation of Patch Test Findings in Patients With Anogenital Dermatitis. JAMA Dermatol. 2020. PMID: 31774454. doi:10.1001/jamadermatol.2019.3844

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。